Steven J Miles

US Patent:

61024066, Aug 15, 2000

Filed:

Jun 7, 1999

Appl. No.:

9/326871

Inventors:

Steven A. Miles - Sherman Oaks CA
G. Michael Wool - Los Angeles CA

International Classification:

A63F 918

US Classification:

273430

Abstract:

An Internet-based service configured to operate a scavenger hunt in which participants are required to answer questions using information obtained from one or more Web sites visited in response to hints suggesting where such information may be located. Each preceding question must be successfully answered before a next question is presented. Generally, a correct answer requires verification that a respondent visited the Web site at which the information required in the answer is located. This, in turn, may require that the respondent reached the Web site at which the information required in the answer is located through an authorized path including at least one predetermined Web address. Such verification may be achieved by using referring uniform resource locator (URL) information regarding the at least one Web address as a security key to allow access to a location at which the respondent may enter the answer. The security key provides access to a secure database used to store answers provided by the participants in the scavenger hunt.

US Patent:

54708249, Nov 28, 1995

Filed:

May 31, 1991

Appl. No.:

7/707863

Inventors:

Steven A. Miles - Sherman Oaks CA
Ronald H. Stevens - Marina Del Rey CA
Otoniel M. Martinez - Valencia CA
Tadamitsu Kishimoto - Osaka, JP
David J. Klashman - Sherman Oaks CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61K 3700

US Classification:

514 2

Abstract:

Substances or agents which diminish the level of IL-6 or its activity in Kaposi's sarcoma-derived cells are useful agents in the treatment of Kaposi's sarcoma. In particular, substances which inhibit the expression of the gene encoding IL-6 or its receptor, or which interfere with the activity of these substances, are useful in the treatment of this condition. In particular, antibodies immunoreactive with these proteins, oligomers which interfere with the production of these materials, or substances which interfere with the activity of other proteins, DNAs or RNAs that regulate the production and activity of IL-6 are thus useful.